Kingman Health Clinic, P.a. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 701 E A Ave, Kingman, KS 67068 Phone: 620-532-5145 Fax: 620-532-2586 |
Advanced Mobile Healthcare And Community Clinic General Practice Medicare: Medicare Enrolled Practice Location: 437 Cedar St, Kingman, KS 67068 Phone: 620-553-5040 Fax: 620-553-5029 |
Kingman Healthcare Center Family Clinic Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 750 W D Ave, Kingman, KS 67068 Phone: 620-532-0295 Fax: 855-483-0002 |
Kingman Chiropractic Center Clinic/Center Medicare: Medicare Enrolled Practice Location: 108 N Main St, Kingman, KS 67068 Phone: 620-532-2225 Fax: 620-532-3621 |
Kingman County Family Medicine,llc Family Medicine Medicare: Medicare Enrolled Practice Location: 132 West A Street, Kingman, KS 67068 Phone: 620-532-5800 Fax: 620-532-3361 |
Kingman Health Clinic, P.a. Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 701 E A Ave, Kingman, KS 67068 Phone: 620-532-5145 Fax: 620-532-2586 |
News Archive
In an article published in the peer-reviewed SPIE publication Journal of Biomedical Optics, "Frequency-domain differential photoacoustic radar: theory and validation for ultra-sensitive atherosclerotic plaque imaging," researchers demonstrate a new imaging modality that successfully identifies the presence of cholesterol in the arterial plaque.
Eating meat from animals grazed on land treated with commonly-used agricultural fertilisers might have serious implications for pregnant women and the future reproductive health of their unborn children, according to a new study involving sheep.
The number of people living with dementia is expected to double to 65.7 million by 2030 and more than triple by 2050, with "the current estimated cost of treating and caring for those with the condition at $604 billion a year," according to a report released Wednesday by the WHO and Alzheimer's Disease International, Agence France-Presse reports.
Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV today announced that they have reached agreement with the U.S. Food and Drug Administration (FDA) on the design of a Phase III clinical study with the investigational drug RHUCIN under the Special Protocol Assessment (SPA) process that is intended to support the submission of a Biologics License Application.
One of the strangest things about the H.I.V. epidemic in the Deep South-;from Louisiana to Alabama to Mississippi-;is how easily most Americans have elided it, choosing instead to imagine that the disease is now an out-there, elsewhere epidemic.
› Verified 2 days ago